Cataracts, dry eyes, glaucoma and other eye problems become more common with age. But these can be treated — and sometimes ...
Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U ...
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
The focus in recent years has shifted to reducing the long-term burden of medical therapy, minimizing the risk of medication ...
Scientists at the University of Toronto are developing a groundbreaking treatment that could replace the need for daily eye ...
Himani Goyal, MD, takes glaucoma care to the next level by embracing advancements that extend beyond traditional treatment ...
Aster Hospital Al Qusais, recognized in Newsweek's“World's Best Smart Hospitals 2025” List among 350 hospitals globally and ...
Hosted on MSN4d
Glaucoma Doesn’t Always Start With Blurry Vision, Here's How To Protect Your EyesightGlaucoma can affect one or both eyes, and some individuals with high eye pressure never develop it. Normal-tension glaucoma ...
Glenmark launches Latanoprost Ophthalmic Solution, targeting $113.5 million market, showcasing commitment to quality eye care ...
Alcon introduces Voyager DSLT in US for the treatment for glaucoma and ocular hypertension: Geneva Thursday, February 20, 2025, 14:00 Hrs [IST] Alcon, the global leader in eye car ...
Alcon (ALC) announced he full U.S. commercial availability of Voyager DSLT, the first and only Direct Selective Laser Trabeculoplasty device .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback